European Society of Toxicology In Vitro > News > ESTIV and ONTOX signs Memorandum of Understanding
29 October 2021

ESTIV and ONTOX signs Memorandum of Understanding

Scope of Collaboration

ESTIV and ONTOX entered into the MoU to jointly conduct the following activities:

  • to share appropriate information related to the activities in the field of research on NAMs to adequate target audiences
  • to jointly organise events with clear mutual benefits for ESTIV and for ONTOX.

The MoU has been signed on 19 October 2021 by ESTIV President, Dr. Helena Kandarova and ONTOX Project Coordinator, Prof. Mathieu Vinken (VUB).


ONTOX is conducting a research project in the context of the European H2020 Research and Innovation Programme SC1-BHC-11-2020 called “Advancing the safety assessment of chemicals without the use of animal testing”. The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. More at: www.ontox-project.eu

Related content

March 9 – the last day to submit your abstracts for VPH2026 Conference in Milan!

This year, VPH 2026, organises the in silico toxicology track in collaboration with the European Society of Toxicology in Vitro ESTIV!

The Final ASPIS Open Symposium: From Innovation to Regulatory Impact

  • News

The Final ASPIS Open Symposium will take place on 2–3 July 2026 in Maastricht, the Netherlands, as a satellite event of the ESTIV 2026 Congress. This closing edition marks the culmination of five years of collaboration across the ASPIS cluster and shifts the focus firmly toward impact.

ESTIV/ASCCT Announcement on SOT: Qureator Hands-On Event March 22, 2026

The Physicians Committee for Responsible Medicine and Qureator are hosting a FREE in-person workshop and lab tour…

Silver Sponsor

Communication partners

Memorandum of Understanding